{"id":"W4386331412","doi":"10.1016/s2152-2650(23)01119-9","title":"CLL-617 Long Term Outcomes and Secondary Malignancies in 673 Patients Treated With Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL) in British Columbia (BC), CanadaElys","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Fludarabine; Chronic lymphocytic leukemia; Medicine; Rituximab; Oncology; Internal medicine; Immunology; Leukemia; Antibody; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002155193,0.0002465194,0.0003923156,0.0004391267,0.001383725,0.0009703198,0.0006245545,0.0004740944,0.002289191],"category_scores_gemma":[0.0006799177,0.000280297,0.0004941942,0.001406727,0.000435358,0.0002562081,0.0004671278,0.0008208252,0.0003402734],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01039952,"about_ca_system_score_gemma":0.007379481,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8863929,"about_ca_topic_score_gemma":0.9321347,"domain_scores_codex":[0.9995531,0.00003746222,0.00003129859,0.00007086601,0.00009764615,0.0002095787],"domain_scores_gemma":[0.99928,0.00005059991,0.0001422779,0.0000209319,0.0001968567,0.0003092778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006010332,0.00006312619,0.9946654,0.00001984642,0.0001017555,0.000208428,0.0001634076,0.0001007191,0.0002648598,0.00002451763,0.0008370215,0.002949853],"study_design_scores_gemma":[0.00005229129,0.00009303926,0.9981896,0.00001824835,0.00007284067,0.0001521091,0.0004723631,0.0001003856,0.0000686524,0.00001308326,0.0007594042,0.000007853591],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954304,0.0007166298,0.00002786511,0.0001304491,0.00001145208,0.00001711895,0.001999408,0.000005685738,0.001660949],"genre_scores_gemma":[0.9969818,0.0003586838,0.00002439418,0.0001119263,0.000008672569,0.00001064585,0.001581496,0.000003187546,0.000919192],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1136071,"threshold_uncertainty_score":0.2285523,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02550322466065646,"score_gpt":0.3043011085386214,"score_spread":0.2787978838779649,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}